172 related articles for article (PubMed ID: 12795734)
1. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.
Turner B; Myers RE; Hyslop T; Hauck WW; Weinberg D; Brigham T; Grana J; Rothermel T; Schlackman N
J Gen Intern Med; 2003 May; 18(5):357-63. PubMed ID: 12795734
[TBL] [Abstract][Full Text] [Related]
2. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.
Myers RE; Hyslop T; Gerrity M; Schlackman N; Hanchak N; Grana J; Turner BJ; Weinberg D; Hauck WW
Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):587-93. PubMed ID: 10428195
[TBL] [Abstract][Full Text] [Related]
3. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.
Myers RE; Turner B; Weinberg D; Hauck WW; Hyslop T; Brigham T; Rothermel T; Grana J; Schlackman N
Prev Med; 2001 Oct; 33(4):249-60. PubMed ID: 11570828
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of complete diagnostic examination in clinical practice settings.
Jimbo M; Meyer B; Hyslop T; Cocroft J; Turner BJ; Weinberg DS; Myers RE
Cancer Detect Prev; 2006; 30(6):545-51. PubMed ID: 17113240
[TBL] [Abstract][Full Text] [Related]
5. Measuring complete diagnostic evaluation in colorectal cancer screening.
Myers RE; Fishbein G; Hyslop T; Hauck WW; Kutch M; Grana JR; Schlackman N
Cancer Detect Prev; 2001; 25(2):174-82. PubMed ID: 11341353
[TBL] [Abstract][Full Text] [Related]
6. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation.
Jimbo M; Myers RE; Meyer B; Hyslop T; Cocroft J; Turner BJ; Weinberg DS
Ann Fam Med; 2009; 7(1):11-6. PubMed ID: 19139444
[TBL] [Abstract][Full Text] [Related]
7. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening.
Myers RE; Turner B; Weinberg D; Hyslop T; Hauck WW; Brigham T; Rothermel T; Grana J; Schlackman N
Prev Med; 2004 Apr; 38(4):375-81. PubMed ID: 15020170
[TBL] [Abstract][Full Text] [Related]
8. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
[TBL] [Abstract][Full Text] [Related]
9. Barriers to full colon evaluation for a positive fecal occult blood test.
Fisher DA; Jeffreys A; Coffman CJ; Fasanella K
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1232-5. PubMed ID: 16775188
[TBL] [Abstract][Full Text] [Related]
10. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
[TBL] [Abstract][Full Text] [Related]
11. Predictors of colorectal cancer screening in diverse primary care practices.
Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
[TBL] [Abstract][Full Text] [Related]
12. Family physicians' choices of and opinions on colorectal cancer screening modalities.
Zettler M; Mollon B; da Silva V; Howe B; Speechley M; Vinden C
Can Fam Physician; 2010 Sep; 56(9):e338-44. PubMed ID: 20841573
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy.
Scheitel SM; Ahlquist DA; Wollan PC; Hagen PT; Silverstein MD
Mayo Clin Proc; 1999 Dec; 74(12):1207-13. PubMed ID: 10593348
[TBL] [Abstract][Full Text] [Related]
15. A national survey of primary care physicians' methods for screening for fecal occult blood.
Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
[TBL] [Abstract][Full Text] [Related]
16. Patient preferences for colorectal cancer screening.
Leard LE; Savides TJ; Ganiats TG
J Fam Pract; 1997 Sep; 45(3):211-8. PubMed ID: 9300000
[TBL] [Abstract][Full Text] [Related]
17. Is barium enema an adequate diagnostic test for the evaluation of patients with positive fecal occult blood?
Ramos C; De Jesús-Caraballo J; Toro DH; Ojeda A; Martínez-Souss J; Dueño MI; Cruz-Correa M
Bol Asoc Med P R; 2009; 101(2):23-8. PubMed ID: 19954097
[TBL] [Abstract][Full Text] [Related]
18. Role of double-contrast barium enema in colorectal cancer screening based on fecal occult blood.
Ciatto S; Castiglione G
Tumori; 2002; 88(2):95-8. PubMed ID: 12088265
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the management of positive fecal occult blood tests.
Rao SK; Schilling TF; Sequist TD
J Gen Intern Med; 2009 Mar; 24(3):356-60. PubMed ID: 19130147
[TBL] [Abstract][Full Text] [Related]
20. Improving colorectal cancer screening in family medicine: an Oklahoma Physicians Resource/Research Network (OKPRN) study.
Scheid DC; Hamm RM; Ramakrishnan K; McCarthy LH; Mold JW;
J Am Board Fam Med; 2013; 26(5):498-507. PubMed ID: 24004701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
